ACTR-39. PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE

Authors: Anna Piotrowski, Vinay Puduvalli, Patrick Wen, Jian Campian, Howard Colman, Michael Pearlman, Nicholas Butowski, James Battiste, Jon Glass, Timothy Cloughesy, David Schiff, Martin van den Bent, Tobias Walbert, Manmeet Ahluwalia, Michael Badruddoja, Amandeep Kalra, Dawit Aregawi, Michael Weller, Vanitha Ramakrishnan, Kathy Zhang, Katie Wood, Ingo Mellinghoff, Kent Shih

Published: 2019-11-11

DOI: 10.1093/neuonc/noz175.081

Source: Full article

ACTR-39. PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE

Abstract